TCR2

TCR2

A development stage company focusing on development of biological drugs and engineering T cells for cancer therapy
Cambridge United States (HQ)

TCR2 Company information

Edit
Date
Employees
89 people
Ownership
Firm valuation
€455—682m (Dealroom.co estimates Mar 2018.)
  • Edit
DateInvestorsAmountRound
N/A$3.8mSERIES A
$44.5mSERIES A
$125mSERIES B
N/AN/AIPO
Total FundingFunding not available

Recent News about TCR2

Edit
LocationEdit
United States, Cambridge
Are you an employee or an investor of this company?
Add your profile